Europe Nuclear Imaging Market - Growth, Trends And Forecasts (2016 - 2021)

Europe Nuclear Imaging Market - Growth, Trends And Forecasts (2016 - 2021)

Purchase Report

The North American Nuclear imaging market is growing at a healthy trend. Nuclear imaging is the use of radioisotopes for the diagnosis of diseases. The two major types of Nuclear imaging used commonly are PET and SPECT. Till recently, SPECT imaging was the mainstream modality for nuclear medicine applications like nuclear cardiology procedures. However, the trend is soon going to change because of global shortage of molybdenum-99 isotope which is in turn will lead to shortage of Technetium-99, which is the daughter product of molybdenum. Hence, PET imaging products which include hybrid PET-CT scanners hold a potential market size in coming years. The cost associated with PET-CT service can be as high as $275,000 per year. PET market is expected to witness more growth compared to SPECT imaging as it provides higher resolution images and the lack of availability of technetium-99m is propelling industry to look for alternative diagnostic procedures. Analyzing the application segment of SPECT and PET, PET is majorly being used in oncology because of good quality of imaging while SPECT is majorly used in cardiology segment accounting for almost 90% of the market share in cardiology. The European countries have a rising aging population and disease incidence and require advanced technologies like nuclear imaging for diagnosis of diseases. There are good healthcare facilities available making these technologies more accessible. The high per capita income makes these facilities affordable. These are the drivers of the European Nuclear imaging market.

Market is segmented into two major segments SPECT (Technetium-99m (TC-99m), Thallium-201 (TL-201), Iodine (I-123) and others) and PET (Fluorine-18, Rubidium-82 (RB-82) and others). The Market is segmented based on application market into SPECT (cardiology, lymphoma, thyroid, neurology and others) and PET (oncology, cardiology, neurology and others),by geography market (UK, France, Germany, Italy and others). Major players in the market are Cardiarc Ltd., Digirad Corporation, Gamme Medica Inc., GE healthcare, Hologic Inc. etc.

Drivers:

Major factors for the growth of the market are increasing use of SPECT and PET analysis in radiopharmaceuticals, increased awareness of people for radiopharmaceuticals, and ready availability of radiopharmaceuticals. Novel applications such as Alzheimers and continually expanding oncology application segment also drive the market.

Constraints:

The short half- life of radioisotopes, high capital investment, regulatory guidelines and reimbursement issues are the constraints in this market.

What the report offers?

  • Market Definition for the specified topic along with identification of key drivers and restraints for the market.
  • Market analysis for the European Nuclear Market in Healthcare Industry, with region specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
  • Identification and analysis of the Macro and Micro factors that affect the European Nuclear imaging Market in Healthcare Industry on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information

1. Introduction

1.1 Report Description

1.2 Markets Covered

1.3 Research Methodology

2. Executive Summary

3. Market Overview

3.1 Market Definition

3.2 Market Drivers

3.3 Market Restraints

3.4 Market Opportunities

3.5 Threat

4. Market Segmentation

4.1 Diagnostic Technologies

4.1.1 SPECT Radioisotopes

4.1.1.1 Technetium-99m (TC-99m)

4.1.1.2 Thallium-201 (TL-201)

4.1.1.3 Iodine (I-123)

4.1.1.4  Others

4.1.2 PET Radioisotopes

4.1.2.1 Fluorine-18

4.1.2.2 Rubidium-82 (RB-82)

4.1.2.3 Others

4.2  By Applications

4.2.1 SPECT

4.2.1.1 Cardiology

4.2.1.2 Lymphoma

4.2.1.3  Thyroid

4.2.1.4 Neurology

4.2.1.5  Others

4.2.2 PET

4.2.2.1  Oncology

4.2.2.2 Cardiology

4.2.2.3 Neurology

4.2.2.4  Others

4.3 By Geography

4.3.1 Europe

4.3.1.1 UK

4.3.1.2 Germany

4.3.1.3 Italy

4.3.1.4 France

4.3.1.5 Others

5. Porters Five Force Analysis

5.1 Bargaining Power of suppliers

5.2 Bargaining power of buyers

5.3 Degree of competition

5.4 Threat of substitution

5.5 Threat of new entrants

6. Competitive Landscape

6.1 Mergers & Acquisitions

6.2 Agreements, Collaborations & Partnerships

6.3 New Product Launches

6.4 Recommendations to new market players

7.  Company profiles

7.1 AGFA-GEVAERT N.V.

7.2 CARDIARC LTD

7.3 DIGIRAD CORPORATION

7.4  GAMMA MEDICA INC

7.5 GE HEALTHCARE

7.6 HOLOGIC INC.

7.7 MEDX INC

7.8 NAVISCAN INC

7.9 POSITRON CORPORATION

7.10 SEGAMI CORPORATION

7.11  SIEMENS HEALTHCARE

8. List of Tables

9. European Nuclear Imaging Market by Diagnostic technology ($millions) (2014-2020)

10. European Nuclear Imaging Market by SPECT radioisotopes ($millions) (2014-2020)

11. European Nuclear Imaging Market by Technetium ($millions) (2014-2020)

12. European Nuclear Imaging Market by Thallium ($millions) (2014-2020)

13. European Nuclear Imaging Market by Iodine ($millions) (2014-2020)

14. European Nuclear Imaging Market by other Types in SPECT ($millions) (2014-2020)

15. European Nuclear Imaging Market by PET radioisotopes ($millions) (2014-2020)

16. European Nuclear Imaging Market by Fluorine-18 ($millions) (2014-2020)

17. European Nuclear Imaging Market by Rubidium-82 ($millions) (2014-2020)

18. European Nuclear Imaging Market by Others ($millions) (2014-2020)

19. European Nuclear Imaging Market by Applications ($millions) (2014-2020)

20. European Nuclear Imaging Market by SPECT- Cardiology ($millions) (2014-2020)

21. European Nuclear Imaging Market by SPECT-Lymphoma ($millions) (2014-2020)

22. European Nuclear Imaging Market by SPECT- Thyroid ($millions) (2014-2020)

23. European Nuclear Imaging Market by SPECT-Neurology ($millions) (2014-2020)

24. European Nuclear Imaging Market by SPECT-Others ($millions) (2014-2020)

25. European Nuclear Imaging Market by PET-Oncology ($millions) (2014-2020)

26. European Nuclear Imaging Market by PET- Cardiology ($millions) (2014-2020)

27. European Nuclear Imaging Market by PET-Neurology ($millions) (2014-2020)

28. European Nuclear Imaging Market by PET-Others ($millions) (2014-2020)

29. European Nuclear Imaging Market by Countries ($millions) (2014-2020)

30. UK Nuclear Imaging Market by Diagnostic technology ($millions) (2014-2020)

31. UK Nuclear Imaging Market by SPECT radioisotopes ($millions) (2014-2020)

32. UK Nuclear Imaging Market by Technetium ($millions) (2014-2020)

33. UK Nuclear Imaging Market by Thallium ($millions) (2014-2020)

34. UK Nuclear Imaging Market by Iodine ($millions) (2014-2020)

35. UK Nuclear Imaging Market by other Types in SPECT ($millions) (2014-2020)

36. UK Nuclear Imaging Market by PET radioisotopes ($millions) (2014-2020)

37. UK Nuclear Imaging Market by Fluorine-18 ($millions) (2014-2020)

38. UK Nuclear Imaging Market by Rubidium-82 ($millions) (2014-2020)

39. UK Nuclear Imaging Market by Others ($millions) (2014-2020)

40. UK Nuclear Imaging Market by Applications ($millions) (2014-2020)

41. UK Nuclear Imaging Market by SPECT- Cardiology ($millions) (2014-2020)

42. UK Nuclear Imaging Market by SPECT-Lymphoma ($millions) (2014-2020)

43. UK Nuclear Imaging Market by SPECT- Thyroid ($millions) (2014-2020)

44. UK Nuclear Imaging Market by SPECT-Neurology ($millions) (2014-2020)

45. UK Nuclear Imaging Market by SPECT-Others ($millions) (2014-2020)

46. UK Nuclear Imaging Market by PET-Oncology ($millions) (2014-2020)

47. UK Nuclear Imaging Market by PET- Cardiology ($millions) (2014-2020)

48. UK Nuclear Imaging Market by PET-Neurology ($millions) (2014-2020)

49. UK Nuclear Imaging Market by PET-Others ($millions) (2014-2020)

50. UK Nuclear Imaging Market by Countries ($millions) (2014-2020)

51. Germany Nuclear Imaging Market by Diagnostic technology ($millions) (2014-2020)

52. Germany Nuclear Imaging Market by SPECT radioisotopes ($millions) (2014-2020)

53. Germany Nuclear Imaging Market by Technetium ($millions) (2014-2020)

54. Germany Nuclear Imaging Market by Thallium ($millions) (2014-2020)

55. Germany Nuclear Imaging Market by Iodine ($millions) (2014-2020)

56. Germany Nuclear Imaging Market by other Types in SPECT ($millions) (2014-2020)

57. Germany Nuclear Imaging Market by PET radioisotopes ($millions) (2014-2020)

58. Germany Nuclear Imaging Market by Fluorine-18 ($millions) (2014-2020)

59. Germany Nuclear Imaging Market by Rubidium-82 ($millions) (2014-2020)

60. Germany Nuclear Imaging Market by Others ($millions) (2014-2020)

61. Germany Nuclear Imaging Market by Applications ($millions) (2014-2020)

62. Germany Nuclear Imaging Market by SPECT- Cardiology ($millions) (2014-2020)

63. Germany Nuclear Imaging Market by SPECT-Lymphoma ($millions) (2014-2020)

64. Germany Nuclear Imaging Market by SPECT- Thyroid ($millions) (2014-2020)

65. Germany Nuclear Imaging Market by SPECT-Neurology ($millions) (2014-2020)

66. Germany Nuclear Imaging Market by SPECT-Others ($millions) (2014-2020)

67. Germany Nuclear Imaging Market by PET-Oncology ($millions) (2014-2020)

68. Germany Nuclear Imaging Market by PET- Cardiology ($millions) (2014-2020)

69. Germany Nuclear Imaging Market by PET-Neurology ($millions) (2014-2020)

70. Germany Nuclear Imaging Market by PET-Others ($millions) (2014-2020)

71. Germany Nuclear Imaging Market by Countries ($millions) (2014-2020)

72. France Nuclear Imaging Market by Diagnostic technology ($millions) (2014-2020)

73. France Nuclear Imaging Market by SPECT radioisotopes ($millions) (2014-2020)

74. France Nuclear Imaging Market by Technetium ($millions) (2014-2020)

75. France Nuclear Imaging Market by Thallium ($millions) (2014-2020)

76. France Nuclear Imaging Market by Iodine ($millions) (2014-2020)

77. France Nuclear Imaging Market by other Types in SPECT ($millions) (2014-2020)

78. France Nuclear Imaging Market by PET radioisotopes ($millions) (2014-2020)

79. France Nuclear Imaging Market by Fluorine-18 ($millions) (2014-2020)

80. France Nuclear Imaging Market by Rubidium-82 ($millions) (2014-2020)

81. France Nuclear Imaging Market by Others ($millions) (2014-2020)

82. France Nuclear Imaging Market by Applications ($millions) (2014-2020)

83. France Nuclear Imaging Market by SPECT- Cardiology ($millions) (2014-2020)

84. France Nuclear Imaging Market by SPECT-Lymphoma ($millions) (2014-2020)

85. France Nuclear Imaging Market by SPECT- Thyroid ($millions) (2014-2020)

86. France Nuclear Imaging Market by SPECT-Neurology ($millions) (2014-2020)

87. France Nuclear Imaging Market by SPECT-Others ($millions) (2014-2020)

88. France Nuclear Imaging Market by PET-Oncology ($millions) (2014-2020)

89. France Nuclear Imaging Market by PET- Cardiology ($millions) (2014-2020)

90. France Nuclear Imaging Market by PET-Neurology ($millions) (2014-2020)

91. France Nuclear Imaging Market by PET-Others ($millions) (2014-2020)

92. France Nuclear Imaging Market by Countries ($millions) (2014-2020)

93. Italy Nuclear Imaging Market by Diagnostic technology ($millions) (2014-2020)

94. Italy Nuclear Imaging Market by SPECT radioisotopes ($millions) (2014-2020)

95. Italy Nuclear Imaging Market by Technetium ($millions) (2014-2020)

96. Italy Nuclear Imaging Market by Thallium ($millions) (2014-2020)

97. Italy Nuclear Imaging Market by Iodine ($millions) (2014-2020)

98. Italy Nuclear Imaging Market by other Types in SPECT ($millions) (2014-2020)

99. Italy Nuclear Imaging Market by PET radioisotopes ($millions) (2014-2020)

100. Italy Nuclear Imaging Market by Fluorine-18 ($millions) (2014-2020)

101. Italy Nuclear Imaging Market by Rubidium-82 ($millions) (2014-2020)

102. Italy Nuclear Imaging Market by Others ($millions) (2014-2020)

103. Italy Nuclear Imaging Market by Applications ($millions) (2014-2020)

104. Italy Nuclear Imaging Market by SPECT- Cardiology ($millions) (2014-2020)

105. Italy Nuclear Imaging Market by SPECT-Lymphoma ($millions) (2014-2020)

106. Italy Nuclear Imaging Market by SPECT- Thyroid ($millions) (2014-2020)

107. Italy Nuclear Imaging Market by SPECT-Neurology ($millions) (2014-2020)

108. Italy Nuclear Imaging Market by SPECT-Others ($millions) (2014-2020)

109. Italy Nuclear Imaging Market by PET-Oncology ($millions) (2014-2020)

110. Italy Nuclear Imaging Market by PET- Cardiology ($millions) (2014-2020)

111. Italy Nuclear Imaging Market by PET-Neurology ($millions) (2014-2020)

112. Italy Nuclear Imaging Market by PET-Others ($millions) (2014-2020)

113. Italy Nuclear Imaging Market by Countries ($millions) (2014-2020)

Purchase Report

Our Clients Include View All

Looking to Customize Report?

Complete your payment details below

Shipping & Billing Information

Payment Information